Envoy Medical, Inc. (COCH)
Data as of , from SEC Form 4 filings.
See up to 3 months of COCH. The 7-day demo opens the 1M and 3M ranges and puts COCH on your watchlist.
Start 7-day demoLatest COCH insider trades
About Envoy Medical, Inc. (COCH)
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
- WHITE BEAR LAKE, MN
- 47
- 2023
- Nasdaq
COCH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 250,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
COCH insider transactions (Form 4)
5526 Form 4 filings on record, the earliest from Nov 21, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Potashnick - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Grant or award | Stock Option (right to buy) | 1,000,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Grant or award | Restricted Stock Units | 1,000,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Grant or award | Class A Common Stock | 32,856 | $5.99 | $20K | |
| Chas McKhann - Director | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Mona Chetan Patel - Director | Open-market purchase | Class A Common Stock | 312,500 | $4.00 | $125K | |
| Mona Chetan Patel - Director | Open-market purchase | Warrant (right to buy) | 187,500 | $0.00 | - | |
| Mona Chetan Patel - Director | Open-market purchase | Warrant (right to buy) | 312,500 | $0.00 | - | |
| Robert Potashnick - Officer | Open-market purchase | Class A Common Stock | 212,500 | $4.00 | $85K | |
| Robert Potashnick - Officer | Open-market purchase | Warrant (right to buy) | 127,500 | $0.00 | - | |
| Robert Potashnick - Officer | Open-market purchase | Warrant (right to buy) | 212,500 | $0.00 | - | |
| Susan Kantor - Director | Open-market purchase | Class A Common Stock | 96,150 | $4.00 | $38K | |
| Susan Kantor - Director | Open-market purchase | Warrant (right to buy) | 57,690 | $0.00 | - | |
| Susan Kantor - Director | Open-market purchase | Warrant (right to buy) | 96,150 | $0.00 | - | |
| Charles Brynelsen - Director | Open-market purchase | Class A Common Stock | 1,000,000 | $4.00 | $400K | |
| Charles Brynelsen - Director | Open-market purchase | Warrant (right to buy) | 600,000 | $0.00 | - | |
| Charles Brynelsen - Director | Open-market purchase | Warrant (right to buy) | 1,000,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Open-market purchase | Class A Common Stock | 62,500 | $4.00 | $25K | |
| Brent T. Lucas - Officer | Open-market purchase | Warrant (right to buy) | 37,500 | $0.00 | - | |
| Brent T. Lucas - Officer | Open-market purchase | Warrant (right to buy) | 62,500 | $0.00 | - | |
| Glen A. Taylor - 10% Owner | Open-market purchase | Class A Common Stock | 18,750,000 | $4.00 | $7.50M | |
| Glen A. Taylor - 10% Owner | Open-market purchase | Warrant Shares (Series A-1) | 11,250,000 | $0.00 | - | |
| Glen A. Taylor - 10% Owner | Open-market purchase | Warrant Shares (Series A-2) | 18,750,000 | $0.00 | - | |
| Robert Potashnick - Officer | Grant or award | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Grant or award | Stock Option (right to buy) | 200,000 | $0.00 | - | |
| Janis Smith-Gomez - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Michael Curtis Crowe - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Mona Chetan Patel - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Charles Brynelsen - Director | Grant or award | Stock Option (right to buy) | 62,500 | $0.00 | - | |
| Susan Kantor - Director | Grant or award | Stock Option (right to buy) | 62,500 | $0.00 | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 250,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 250,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 250,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 250,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 500,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 750,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 750,000 | - | - | |
| Glen A. Taylor - Director | Derivative | Warrant (right to buy) | 750,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 750,000 | - | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 750,000 | $0.00 | - | |
| Anzu SPAC GP I LLC | Other | Class A Common Stock, par value $0.0001 per share | 1,028,986 | $0.00 | - | |
| Anzu SPAC GP I LLC | Other | Class A Common Stock, par value $0.0001 per share | 2,028,986 | $0.00 | - | |
| Anzu SPAC GP I LLC | Other | Series A Preferred Stock, par value $0.0001 per share | 373,333 | $0.00 | - | |
| Susan Kantor | Other | Class A Common Stock | 34,705 | $0.00 | - | |
| Glen A. Taylor - Director | Grant or award | Warrant (right to buy) | 500,000 | $0.00 | - | |
| Brent T. Lucas - Officer | Open-market purchase | Warrant (right to buy) | 94,293 | $0.55 | $5K | |
| Brent T. Lucas - Officer | Open-market purchase | Warrant (right to buy) | 16,694 | $0.60 | $1K | |
| Mona Chetan Patel - Director | Open-market purchase | Class A Common Stock | 2,500 | $22.79 | $6K | |
| Anzu SPAC GP I LLC - 10% Owner | Other | Class A Common Stock, par value $0.0001 per share | 1,000,000 | $0.00 | - | |
| Susan Kantor - Director | Other | Class A Common Stock | 18,182 | $0.00 | - |
COCH insider trading FAQ
What is the latest insider trade for COCH?
Envoy Medical, Inc. (COCH) had 1 insider filing in the last 90 days, with the most recent on 26 August 2026. The full record for COCH runs to 26 Form 4 filings, the earliest from 21 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying COCH stock?
No insider purchases of COCH were filed in the last 90 days. 21 purchases are on record for this company.
How many insiders are selling COCH stock?
No insider sales of COCH were filed in the last 90 days.
Where can I see COCH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects COCH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert Potashnick view on EDGAR
- - Brent T. Lucas view on EDGAR
- - Brent T. Lucas view on EDGAR
- - Chas McKhann view on EDGAR
- - Mona Chetan Patel view on EDGAR
- - Robert Potashnick view on EDGAR
- - Susan Kantor view on EDGAR
- - Charles Brynelsen view on EDGAR
- - Brent T. Lucas view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where COCH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow COCH with a 7-day demo
- COCH on your watchlist
- Every COCH Form 4 filing on record
- Up to 3 months of COCH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
